The EGFR, AR and T-cell receptor, as well as several classes of G-protein coupled receptors appeared to be significantly altered during prostate cancer initiation (Table 4), the transition from primary to metastatic prostate cancer (Table 3), and in case of disease recurrence (Table 5). This evidence concerns the gene EGFR and prostate carcinoma.